Equities

Fidson Healthcare PLC

FIDSON:LAG

Fidson Healthcare PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NGN)14.30
  • Today's Change-0.05 / -0.35%
  • Shares traded17.07k
  • 1 Year change+68.24%
  • Beta0.5785
Data delayed at least 60 minutes, as of Apr 26 2024 14:14 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fidson Healthcare Plc is a Nigeria-based pharmaceutical manufacturing company. The principal activities of the Company include manufacturing and distribution of pharmaceutical products. The Company's segments include over-the-counter, ethical products and consumer. The over-the-counter segment represents the products that may be sold directly to the consumer without a prescription. The ethical products segment represents drugs, injectables and infusions, which will be sold to the consumer only on the possession of a valid prescription. The consumer segment represents household items. It provides services, including formulation/development, contract manufacturing and production of medicines. Its products include Anti Infective & Anti Malaria, Central Nervous System (CNS), Gastrointestinal Medicines, Supplements, Topical/Dermatological Medicines, Vitamins & Minerals, Ophthalmic Solution and others. Its Ophthalmic Solution helps manage and treat eye conditions.

  • Revenue in NGN (TTM)53.05bn
  • Net income in NGN3.61bn
  • Incorporated1995
  • Employees593.00
  • Location
    Fidson Healthcare PLC268, Ikorodu Road, ShomoluP.O.Box 7210LAGOS NigeriaNGA
  • Phone+234 3429102
  • Fax+234 3429106
  • Websitehttps://www.fidson.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.